REYNO LEONARD 4/A
4/A · C4 Therapeutics, Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4/AAmended
REYNO LEONARD
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-07-10$1.99/sh−7,382$14,690→ 166,382 total - Exercise/Conversion
Common Stock
2025-07-10+15,325→ 173,764 total
Footnotes (2)
- [F1]This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.